You are here

  • Home
  • Archive
  • Volume 9, Issue 8
  • Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?

Article metrics

Article menu

Download PDFPDF

XML
Hypothesis
Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2024

AbstractFullPdf
Aug 202123323346
Sep 202115515537
Oct 2021919114
Nov 2021888820
Dec 2021747410
Jan 2022697121
Feb 202224245
Mar 202228308
Apr 2022768118
May 2022808012
Jun 2022919431
Jul 2022606112
Aug 2022565711
Sep 2022717118
Oct 202262628
Nov 2022495119
Dec 2022424210
Jan 202343438
Feb 202358584
Mar 202358598
Apr 202329295
May 2023494913
Jun 202350506
Jul 2023626316
Aug 202360628
Sep 2023676916
Oct 2023838311
Nov 202320020011
Dec 2023828211
Jan 202437388
Feb 2024444411
Mar 2024787950
Total23492373486